Results 21 to 30 of about 3,750,451 (195)

Antiplatelet agents for preventing pre-eclampsia and its complications.

Cochrane Database of Systematic Reviews, 2019
BACKGROUND Pre-eclampsia is associated with deficient intravascular production of prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and stimulant of platelet aggregation. These observations led to the hypotheses that
L. Duley, S. Meher, K. Hunter, A. Seidler, L. Askie   +4 more
semanticscholar   +1 more source

Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack.

Cochrane Database of Systematic Reviews, 2020
BACKGROUND Stroke is a leading cause of morbidity and mortality worldwide. Antiplatelet agents are considered to be the cornerstone for secondary prevention of stroke, but the role of using multiple antiplatelet agents early after stroke or transient ...
I. Naqvi, A. Kamal, H. Rehman
semanticscholar   +1 more source

Antiplatelet therapy in patients with myocardial infarction with non-obstructive coronary arteries: A clinical perspective

Frontiers in Cardiovascular Medicine, 2023
Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a heterogeneous group of diseases with different pathological mechanisms, and it is uncertain whether the classical secondary prevention and treatment strategies for myocardial ...
Wenjie Chen, Wenjie Chen, Yufeng Jiang, Yufeng Jiang, Tan Chen, Tan Chen, Yafeng Zhou, Yafeng Zhou   +7 more
doaj   +1 more source

ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)

Acta Biomedica Scientifica, 2017
The literature review provides basic information about cerebral stroke as one of the leading medical and socio-economic problems that caused high levels of mortality and morbidity from stroke, unfavorable disability index. This fact confirms the need for
E. Y. Kitaeva, V. V. Shprakh
doaj   +1 more source

ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE

Рациональная фармакотерапия в кардиологии, 2015
Alternative approaches to the use of two component antiplatelet therapy in patients with acute coronary syndrome are discussed. Reasons to the development and implementation of new, more powerful antiplatelet agents are considered.
S. R. Gilyarevskiy, V. A. Orlov, I. M. Kuz'mina, A. G. Larin   +3 more
doaj   +3 more sources

Outcomes of trauma patients on chronic antithrombotic therapies in a trauma center in a rural state

Surgery in Practice and Science, 2023
Objective: The number of trauma patients presenting with chronic antithrombotic therapy is on the rise. The risk of hemorrhage, the leading cause of death in trauma patients, increases for those on such therapy.
Benjamin Moore, Hanna Jensen, MD PhD, Karan Patel, Zeel Modi, Rebecca J Reif, Shibani Lal, Stephen M Bowman, Melissa Kost, Kyle J. Kalkwarf, Joseph Margolick, Avi Bhavaraju, Howard L. Corwin   +11 more
doaj   +1 more source

Factors related to postoperative vitreous hemorrhage after small-gauge vitrectomy in proliferative diabetic retinopathy patients

BMC Ophthalmology, 2023
Background The role of anticoagulation or antiplatelet on post-vitrectomy vitreous hemorrhage (POVH) in patients with proliferative diabetic retinopathy (PDR) is rarely investigated in the small-gauge vitrectomy era.
Meng Zhao, Aman Chandra, Jun Xu, Jipeng Li   +3 more
doaj   +1 more source

Systemic antiplatelet agents and anticoagulants in eyes with branch retinal vein occlusion

Therapeutic Advances in Ophthalmology, 2021
Purpose: The purpose of this study was to investigate the effect of systemic antiplatelet agents and anticoagulants on the structural and functional outcomes of eyes with branch retinal vein occlusion (BRVO).
Pali P. Singh, Durga S. Borkar, Cason B. Robbins, Jane S. Kim, Faith Birnbaum, Maria Gomez-Caraballo, Akshay S. Thomas, Sharon Fekrat   +7 more
doaj   +1 more source

Efficacy and safety of various antithrombotic regimens after left atrial appendage occlusion

Кардиоваскулярная терапия и профилактика, 2022
Aim. To evaluate the efficacy and safety of various antithrombotic regimens after left atrial appendage occlusion (LAAO) in real clinical practice.Material and methods.
D. V. Pevsner, Yu. K. Rytova, I. Merkulova, E. V. Merkulov   +3 more
doaj   +1 more source

Platelet-Derived Extracellular Vesicles as Target of Antiplatelet Agents. What Is the Evidence?

Frontiers in Pharmacology, 2019
Platelet-derived large extracellular vesicles (often referred to as microparticles in the field of cardiovascular disease) have been identified as effector in the atherothrombotic process, therefore representing a target of pharmacological intervention ...
F. Taus, A. Meneguzzi, M. Castelli, P. Minuz   +3 more
semanticscholar   +1 more source